There are TauRx with their tau aggregation inhibitor (formulated of methylene blue) and Noscira with an inhibitor of tau phosphorylation. Think both in phase II (not following closely), but I don't have high hopes here. Thing about tau is figuring out how to target it and I think it will take few more years before tau based therapies will take off.
News 
Market Data 
Discover 
